United States Department of Defense (DOD)- Incoming Subaward
Title: Treat Implant loosening of Percutaneous Osseointegrated Prosthetic Limbs with Intermittent Parathyroid Hormone
Principal Investigator: Matthew Greenblatt, MD PhD
Period of Support: 09/01/2021-08/31/2024
Total Direct Costs: $54,117
The Pershing Square Sohn Cancer Research Alliance
Title: Evolution and antigenicity of complex amplicons
Principal Investigator: Marcin Imielinski, MD PhD
Period of Support: 07/01/2021-06/30/2024
Total Direct Costs: $545,454
National Institutes of Health (R37)
Title: Cell-of-Origin Footprints of Passenger Mutations in Human Lung Cancer
Principal Investigator: Marcin Imielinski, MD PhD
Period of Support:09/23/2021-08/31/2026
Total Direct Costs: $1,718,599
Breast Cancer Research Foundation
Title: Isolation and Characterization of Metastatic Breast Cancer Cell-of-Origin
Principal Investigator: Tan Ince, MD PhD
Period of Support:10/01/2021-09/30/2022
Total Direct Costs: $158,333
National Institutes of Health (RM1)- Incoming Subaward
Title: Structure, Function, and Dynamics of Large Molecular Complexes that Execute and Regulate Genome Function
Principal Investigator: Steven Josefowicz, PhD
Period of Support: 04/01/2021- 03/31/2022
Total Direct Costs: $170,022
National Institutes of Health (SBIR) -Incoming Subaward
Title: Leveraging functional genomics to create an epigenetic toolbox for inflammation research and drug discovery
Principal Investigator: Steven Josefowicz, PhD
Period of Support: 05/01/2021-05/04/2022
Total Direct Costs: $92,091
National Science Foundation
Title: Collaborative Research: SCH: Integrated Analysis of Single-Cell and Spatially Resolved Omics Data
Principal Investigator: Luigi Marchionni, MD PhD
Period of Support: 09/01/2021- 08/31/2025
Total Direct Costs: $147,436
National Institutes of Health (R01)
Title: Interferon regulation by NBR1-driven chaperone-mediated autophagy in stellate cells in liver cancer
Principal Investigator: Jorge Moscat, PhD
Period of Support: 12/01/2021- 11/30/2026
Total Direct Costs: $1,188,336
United States Department of Defense (DOD)
Title: Novel Complex Structural Variants And Epigenetic Alterations Link The Genomes Of Prostate Cancer In African Americans With Outcome Disparity.
Principal Investigator: Juan Miguel Mosquera, MD
Period of Support: 08/15/2021- 08/14/2023
Total Direct Costs: $741,658
STARR Cancer Consortium
Title: Defining the evolution and tumor microenvironment interactions of classic Hodgkin lymphoma through single-cell multi-omics and genetically engineered mouse models
Principal Investigator: Seung Ha (Anna) Nam, MD (Co-PI)
Period of Support: 01/01/2022-12/31/2023
Total Direct Costs: $364,000
STARR Cancer Consortium
Title: Early intervention for the prevention of blood cancer development
Principal Investigator: Seung Ha (Anna) Nam, MD (Co-PI)
Period of Support: 01/01/2022-12/31/2023
Total Direct Costs: $191,000
Weill Cornell Medicine Internal Grants
JumpStart Program
Title: Targeting Drivers of tumor heterogeneity to block neuroendocrine prostate cancer progression
Principal Investigator: Nicholas Brady, PhD
Period of Support:07/01/2021-06/30/2024
Total Direct Costs: $300,000
WCM SPORE in Prostate Cancer Career Enhancement Program
Title: Targeting drivers of tumor heterogeneity to block the progression to NEPC
Principal Investigator: Nicholas Brady, PhD
Period of Support: 09/01/2021- 08/31/2022
Total Direct Costs: $50,000
WCM Prostate Cancer SPORE Developmental Research Program
Title: A versatile patient derived prostate cell culture system
Principal Investigator: Tan Ince, MD PhD
Period of Support: 08/01/2021- 07/31/2022
Total Direct Costs: $75,000
WCM Prostate Cancer SPORE Developmental Research Program
Title: Therapeutic targeting the neuroendocrine prostate cancer stroma
Principal Investigator: Jorge Moscat, PhD and Maria Diaz-Meco, PhD
Period of Support: 09/01/2021- 08/31/2022
Total Direct Costs: $75,000
Clinical & Translational Science Center (CTSC)
Title: Small. Molecule inhibitors of G3BP1 reinvigorate SPOP tumor suppressor
Principal Investigator: Pengbo Zhou, PhD
Period of Support: 07/01/2021-06/30/2022
Total Direct Costs: $50,000
Industry Sponsored Research Agreements
Predictive Oncology, Inc.
Title: SRA: TumorGenesis, Inc – Ovarian cancer cell based panning project
Principal Investigator: Tan Ince, MD PhD
Period of Support: 08/11/2021-08/10/2022
Total Direct Costs: 94,880
Novartis Pharmaceuticals Corp.
Title: Evaluation of eltrombopag interference in total bilirubin, direct bilirubin and creatinine clinical chemistry tests
Principal Investigator: Zhen Zhao, PhD
Period of Support: 10/26/2021-10/25/2022
Total Direct Costs: $74,000
Fellowships
American Association for Cancer Research
Title: Role of the linker histones H1 In lymphomas
Principal Investigator: Antonin Papin, PhD (postdoc in Cesarman Lab)
Period of Support: 07/01/2021- 06/30/2023
Total Direct Costs: $120,000
Fondazione AIRC per la ricerca sul cancro
Title: Deciphering the role of androgen receptor in spatially resolved mesenchymal populations in prostate cancer
Principal Investigator: Filippo Pederzoli, PhD (postdoc in Loda Lab)
Period of Support: 01/01/2022- 12/31/2023
Total Direct Costs: $142,198